GlassScriptPhysician profile
Jay R Connelley
NPI 1649250689
$6,784.80
in general payments reported to CMS, 2019-2025
43 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $53.14 · 2021: $1,255 · 2022: $996 · 2023: $1,464 · 2024: $1,283 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,011.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,402.55 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $1,222.50 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $950.64 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $402.08 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $299.89 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $264.84 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.07 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $163.69 | 2019-2025 | Mounjaro |
| Exact Sciences Corporation | $130.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $115.67 | 2021-2025 | Freestyle Libre 3, Cardiomems |
| Merck Sharp & Dohme LLC | $111.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $102.22 | 2019-2023 | |
| Eisai INC. | $94.04 | 2020-2025 | |
| Astellas Pharma US INC | $88.66 | 2023-2024 | Veozah, Myrbetriq |
| Supernus Pharmaceuticals, INC. | $88.03 | 2021-2025 | Qelbree |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Connelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.